Oscar Health OSCR
$24.73 −$1.44 (-5.50%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $24.95 +0.89%
Open$26.10
Prev close$26.17
Day range$24.55 – $26.78
Volume6.61M
Market cap$7.68B
P/E (TTM)11.0
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$5.14B+72.1% YoY
Net profit$167.30M+221.7% YoY
Diluted EPS$0.49+192.5% YoY
Free cash flow-$1.21B-24.5% YoY
Operating cash flow-$1.20B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Net margin4.9%
Return on equity52.7%
Return on assets10.9%
Liabilities / assets77.8%
Total debt$432.41M
Free cash flow / sales23.7%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $5.14B | $4.88B | $4.65B | $11.70B | $2.81B |
| Total Operating Revenue | $5.14B | $4.88B | $4.65B | $11.70B | $2.81B |
| Total Premiums Earned | $5.04B | $4.79B | $4.58B | $11.47B | $2.75B |
| -Net Premiums Written | $5.72B | $5.66B | $6.02B | $14.07B | $3.55B |
| -Increase Decrease in Net Unearned Premium Reserves | -$677.30M | -$871.47M | -$1.44B | -$2.60B | -$803.30M |
| Fee Revenue and Other Income | $6.30M | $6.10M | $5.72M | $28.59M | $8.97M |
| -Fees and Commissions | $6.30M | $6.10M | $5.72M | $0.00 | -$19.63M |
| Net Investment Income | $91.02M | $84.79M | $60.61M | $202.94M | $49.61M |
| Total Expenses | $4.96B | $4.50B | $3.95B | $12.14B | $3.16B |
| Loss Adjustment Expense | $4.23B | $3.79B | $3.23B | $10.02B | $2.62B |
| Selling and Admin Expenses | $721.89M | $176.94M | $160.08M | $2.05B | $511.03M |
| Depreciation & Amortization | $6.54M | $6.06M | $7.02M | $28.89M | $7.88M |
| $4.73M | $4.71M | $5.38M | $17.60M | -$1.10M | |
| -Interest Expense Non-Operating | $4.73M | $4.71M | $5.38M | $17.60M | -$1.10M |
| Other Operating Expenses | -$2.09M | $188.66M | $196.44M | $23.34M | $20.03M |
| Pretax Profit | $175.38M | $383.01M | $698.77M | -$437.30M | -$352.68M |
| Tax | $8.08M | $21.18M | $19.75M | $5.61M | -$247,000.00 |
| Net Profit | $167.30M | $361.83M | $679.02M | -$442.90M | -$352.43M |
| Profit from Continuing Operations | $167.30M | $361.83M | $679.02M | -$442.90M | -$352.43M |
| Minority Interests | $23,000.00 | $20,000.00 | $27,000.00 | $248,000.00 | $177,000.00 |
| Net Income to Parent Company | $167.28M | $361.81M | $679.00M | -$443.15M | -$352.61M |
| Net Income to Common Stockholders | $167.28M | $365.53M | $682.72M | -$443.15M | -$352.61M |
| Basic EPS | $0.54 | $1.20 | $2.28 | -$1.69 | -$1.24 |
| Diluted EPS | $0.49 | $1.10 | $2.07 | -$1.69 | -$1.24 |
| -General & Admin Expense | – | $176.94M | $160.08M | $2.05B | $511.03M |
| Other Preferred Stock Dividends | – | -$3.72M | -$3.72M | – | – |
| -Other Income Expense | – | – | – | $28.59M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $10.01B | $11.23B | $9.29B | $6.33B | $6.33B |
| Cash and Cash Equivalents | $4.47B | $4.08B | $4.81B | $2.77B | $2.77B |
| Restricted Cash and Cash Equivalents | $27.48M | $29.18M | $28.63M | $32.95M | $32.95M |
| Total Investments | $4.46B | $6.08B | $3.26B | $2.69B | $2.69B |
| -Short Term Investments | $3.02B | $4.48B | $1.99B | $1.22B | $1.22B |
| -Other Invested Assets | $1.44B | $1.60B | $1.27B | $1.47B | $1.47B |
| Receivables | $767.74M | $757.35M | $951.71M | $598.46M | $598.46M |
| -Accounts Receivable | $767.74M | $757.35M | $951.71M | $542.40M | $542.40M |
| Net PPE | $109.31M | $101.49M | $94.19M | $88.35M | $88.35M |
| Other Assets | $173.95M | $182.45M | $148.56M | $144.05M | $144.05M |
| Total Liabilities | $7.78B | $9.17B | $7.62B | $5.34B | $5.34B |
| Policy Holders Liabilities | $160.39M | $167.51M | $172.00M | $166.20M | $166.20M |
| Payables | $6.55B | $8.00B | $6.46B | $4.05B | $4.05B |
| -Accounts Payable | $6.55B | $8.00B | $6.46B | $1.46B | $1.46B |
| Long Term Debt and Capital Lease Obligation | $432.41M | $431.63M | $430.88M | $430.10M | $430.10M |
| -Long Term Debt | $432.41M | $431.63M | $430.88M | $430.10M | $430.10M |
| Other Liabilities | $638.54M | $576.18M | $557.31M | $701.71M | $701.71M |
| Total Equity | $2.23B | $2.06B | $1.67B | $980.74M | $980.74M |
| Stockholders' Equity | $2.22B | $2.05B | $1.66B | $977.65M | $977.65M |
| Capital Stock | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -Common Stock | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| Additional Paid-In Capital | $4.35B | $4.32B | $4.28B | $4.26B | $4.26B |
| Retained Earnings | -$2.09B | -$2.25B | -$2.62B | -$3.29B | -$3.29B |
| Less: Treasury Stock | -$2.92M | -$2.92M | -$2.92M | -$2.92M | -$2.92M |
| Gains/Losses Not Affecting Retained Earnings | -$41.66M | -$8.25M | $5.00M | $18.03M | $18.03M |
| Minority Interests | $3.16M | $3.13M | $3.11M | $3.09M | $3.09M |
| -Other Receivables | – | – | – | $56.07M | $56.07M |
| -Other Payable | – | – | – | $2.59B | $2.59B |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$1.20B | $2.09B | $2.62B | $1.09B | $671.90M |
| Net cash flow from continuing operations | -$1.20B | $2.09B | $2.62B | $1.09B | $671.90M |
| Net Income from Continuing Operations | $167.30M | $361.83M | $679.02M | -$442.90M | -$352.43M |
| Gain/Loss from Continuing Operations | -$175,000.00 | -$1.73M | -$4,000.00 | -$1.34M | -$37,000.00 |
| Deferred Tax | $3.42M | -$1.53M | -$6.20M | $2.45M | $2.62M |
| Other Non-Cash Items | -$36.17M | $48.13M | -$55,000.00 | -$10.74M | $13.28M |
| Change in Working Capital | -$1.36B | $1.67B | $1.93B | $1.46B | $988.37M |
| -Change in Receivables | -$3.34B | $1.52B | $1.64B | $98.57M | $99.07M |
| -Change in Loss and Loss Adjustment Expense Reserves | $25.64M | $164.38M | $278.67M | $98.66M | -$109.01M |
| -Change in Payables and Accrued Expense | $1.96B | $19.87M | -$474,000.00 | $1.20B | $906.59M |
| -Change in Unearned Premiums | -$7.11M | -$4.50M | $5.80M | $91.81M | $89.09M |
| -Change in Other Current Assets | $5.05M | -$32.00M | $5.34M | -$27.12M | $2.64M |
| Net cash flow from investing | $1.58B | -$2.83B | -$590.25M | -$241.06M | -$48.71M |
| Net Cash Flow from Continuing Investing Activities | $1.58B | -$2.83B | -$590.25M | -$241.06M | -$48.71M |
| Net PPE Purchase and Sale | -$11.31M | -$11.76M | -$8.79M | -$36.37M | -$9.06M |
| Net Investment Purchase and Sale | $1.59B | -$2.82B | -$580.60M | -$208.96M | -$40.69M |
| Net Other Investing Changes | -$395,000.00 | $1.47M | -$860,000.00 | $4.28M | $1.05M |
| Financing Cash Flow | $10.85M | $13.30M | -$3.60M | $399.21M | $8.17M |
| Net Cash Flow from Continuing Financing Activities | $10.85M | $13.30M | -$3.60M | $399.21M | $8.17M |
| Proceeds from Stock Option Exercised | $11.92M | $28.77M | $1.14M | $55.03M | $12.84M |
| Net Other Financing Charges | -$1.07M | -$15.47M | -$4.74M | -$65.82M | -$4.67M |
| Ending Cash Balance | $4.49B | $4.10B | $4.83B | $2.80B | $2.80B |
| Net Change in Cash | $389.20M | -$728.97M | $2.03B | $1.25B | $631.37M |
| Beginning Cash Balance | $4.10B | $4.83B | $2.80B | $1.55B | $2.17B |
| Free Cash Flow | -$1.21B | $2.08B | $2.61B | $1.06B | $662.84M |
| Net Issuance Payments of Debt | – | – | – | $410.00M | $0.00 |
No comments yet — be the first to weigh in on OSCR.
Sign in to join the discussion.